Andrew Williamson

Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Pioneer Energy Ltd. generates, distributes and supplies electricity. It offers energy management, market information, asset advisory and management, and contracting services. The company was founded in 1999 and is headquartered in Alexandra, New Zealand.

Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models.

Mimix Biotherapeutics Sàrl is a private company located in Switzerland that develops and commercializes a platform to overcome limitations in tissue engineering, specifically the vascularization challenge and the need for high cell quantities. The Swiss company creates biological architectures with sound using sound-induced morphogenesis, which is a gentle, fast, and easy method to generate multi-cellular, spatially orchestrated tissue constructs using sound waves. The company offers guides for patterning parameters and cells in various hydrogels, including collagen, fibrin, gelatine, and synthetic hydrogels. The company's FastSkin® technology combines micrografting with sound-induced morphogenesis to improve wound care management, addressing a major social burden and unmet clinical need in oncology and chronic wounds treatments. Mimix Biotherapeutics also provides control over cellular and extracellular organization at high spatial resolution to investigate cell-material interactions in vitro models.